Karyopharm Therapeutics, Inc. (KPTI)
8.06
+0.08
(+1.00%)
USD |
NASDAQ |
May 21, 16:00
8.06
0.00 (0.00%)
After-Hours: 19:59
Karyopharm Therapeutics Total Assets (Quarterly) : 131.42M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 56.28B |
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| Oncolytics Biotech, Inc. | 8.161M |
| Altimmune, Inc. | 335.63M |
| Cellectar Biosciences, Inc. | 11.12M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 397.06M |
| Shareholders Equity (Quarterly) | -265.65M |
| Debt to Equity Ratio | -0.8691 |
| Current Ratio | 1.077 |
| Net Debt Paydown Yield | -5.79% |